Previous Article | Next Article 
Molecular and Cellular Biology, March 1999, p. 2322-2329, Vol. 19, No. 3
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
p38 Mitogen-Activated Protein Kinase Can Be
Involved in Transforming Growth Factor
Superfamily Signal
Transduction in Drosophila Wing Morphogenesis
Takashi
Adachi-Yamada,1,*
Makoto
Nakamura,2
Kenji
Irie,1
Yoshinori
Tomoyasu,2
Yorikata
Sano,1
Eiji
Mori,1
Satoshi
Goto,3
Naoto
Ueno,2
Yasuyoshi
Nishida,1 and
Kunihiro
Matsumoto1
Division of Biological Science, Graduate
School of Science, Nagoya University, and CREST, Japan Science and
Technology Corporation, Chikusa-ku, Nagoya
464-8602,1 Division of Morphogenesis,
Department of Developmental Biology, National Institute for Basic
Biology, Myodaiji, Okazaki 444-8585,2 and
Invertebrate Genetics Laboratory, Genetics Strains Research
Center, National Institute of Genetics, Yata, Mishima
411-8540,3 Japan
Received 3 September 1998/Returned for modification 22 October
1998/Accepted 3 December 1998
 |
ABSTRACT |
p38 mitogen-activated protein kinase (p38) has been extensively
studied as a stress-responsive kinase, but its role in development remains unknown. The fruit fly, Drosophila melanogaster,
has two p38 genes, D-p38a and D-p38b. To
elucidate the developmental function of the Drosophila
p38's, we used various genetic and pharmacological manipulations to
interfere with their functions: expression of a dominant-negative form
of D-p38b, expression of antisense D-p38b RNA, reduction of the
D-p38 gene dosage, and treatment with the p38 inhibitor
SB203580. Expression of a dominant-negative D-p38b in the wing imaginal
disc caused a decapentaplegic (dpp)-like phenotype and enhanced the phenotype of a dpp mutant. Dpp
is a secretory ligand belonging to the transforming growth factor
superfamily which triggers various morphogenetic processes through interaction with the receptor Thick veins (Tkv). Inhibition of D-p38b
function also caused the suppression of the wing phenotype induced by
constitutively active Tkv (TkvCA). Mosaic analysis revealed
that D-p38b regulates the Tkv-dependent transcription of the
optomotor-blind (omb) gene in non-Dpp-producing cells, indicating that the site of D-p38b action is downstream of Tkv.
Furthermore, forced expression of TkvCA induced an increase
in the phosphorylated active form(s) of D-p38(s). These results
demonstrate that p38, in addition to its role as a transducer of
emergency stress signaling, may function to modulate Dpp signaling.
 |
INTRODUCTION |
The mitogen-activated protein kinase
(MAPK) is a conserved eukaryotic factor which is integral to various
signal transduction pathways. Three subgroups of the MAPK superfamily
have been identified (5, 12, 33, 41): the extracellular
signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK, also
referred to as stress-activated protein kinase [SAPK]), and p38 (also
called Mpk2). MAPKs are activated through phosphorylation by specific
MAPK kinases (MAPKKs), which are themselves phosphorylated and
activated by specific MAPKK kinases (MAPKKKs), thus comprising a series
of separate MAPK cascades. The ERK cascade plays a central role in the
transduction of mitogenic signals and regulation of development, while
the JNK and p38 cascades have been implicated in the responses to stresses and inflammation. To elucidate the developmental functions of
MAPK cascades, we have used the fruit fly, Drosophila
melanogaster, an excellent organism for the study of cell
signaling pathways through genetic analysis (2). All three
types of MAPK have been identified in Drosophila: an ERK
homolog, Rolled (Rl [4, 10]), a Drosophila
homolog of JNK (DJNK [46, 50]), and
Drosophila homologs of p38 (D-p38a and D-p38b [23,
24]).
The pleiotropic functions of Rl in development have been extensively
characterized (4, 10, 16, 17). Rl is expressed in most
tissues and mediates various receptor tyrosine kinase (RTK)-initiated morphogenetic and mitogenic signaling events
throughout development. At least five RTKs, Btl (Breathless,
a Drosophila homolog of fibroblast growth factor [FGF]
receptor), DER (Drosophila homolog of epidermal growth
factor [EGF] receptor), Htl (Heartless, another Drosophila
homolog of FGF receptor), Sev (Sevenless, a Drosophila
homolog of c-ros), and Tor (Torso), are known to activate the Rl cascade in the processes of tracheal elaboration, cell proliferation, mesodermal patterning, R7 photoreceptor cell
differentiation, and differentiation of embryonic terminal structures,
respectively. Furthermore, immunohistochemical experiments using an
antibody against the phosphorylated form of Rl (16, 17)
revealed an unexpected spatiotemporal pattern of distribution, which
could not be accounted for by known RTK pathways.
Recent studies on DJNK have demonstrated its role in cell morphogenesis
during dorsal closure in the embryo (18, 19, 27, 46, 47,
50). An unknown trigger activates DJNK cascade in the
leading-edge cell of the epithelial cell sheet, which in turn induces
cell shape changes and maintenance of production of Decapentaplegic (Dpp [43]), a secretory ligand belonging to the
transforming growth factor
(TGF-
) superfamily. Both responses,
i.e., cell shape changes and maintenance of Dpp production, are
required for cell sheet movement prior to dorsal closure. As has been
well investigated for mammalian JNK, DJNK is also activated by
stress-inducing and inflammatory stimuli, such as UV irradiation and
lipopolysaccharide (LPS).
The role of D-p38's in inhibiting antimicrobial peptide production in
cultured cells has been reported recently (24). Like mammalian p38 and the yeast homolog HOG1, D-p38's are also activated by stress-inducing and inflammatory stimuli, such as UV irradiation, high osmolarity, heat, serum starvation, H2O2,
and LPS (23, 24). D-p38a and D-p38b function redundantly in
these responses. However, the possible role of D-p38's in
development has remained unknown. Here we show that D-p38b functions in
mediating Dpp signaling in wing morphogenesis. Expression of a
dominant-negative mutant of D-p38b resulted in a
dpp-like wing aberration in wild-type flies and enhanced the
aberrant wing phenotype of a dpp mutant. Moreover,
inhibition of D-p38b function by various means resulted in the
suppression of the phenotype caused by expression of a constitutively
active Dpp receptor. D-p38b was also found to be involved in
controlling Dpp-dependent transcription and was activated by signaling
from constitutively active Dpp receptor.
 |
MATERIALS AND METHODS |
Complementation of the yeast MAPK hog1
mutant.
A Saccharomyces cerevisiae
hog1
::LEU2 strain (7) was
transformed with various plasmids. Transformants were streaked onto yeast extract-peptone-dextrose (YPD) plates containing 0.9 M sorbitol and were incubated at 30°C (see Fig. 1).
Establishment of transgenic flies.
The
UAS-D-p38bantisense construct was made by
inserting the full-length D-p38b cDNA inverted in the P
element vector pUAST (6). UAS-tkvCA
and UAS-tkv+ constructs were made by using the
cDNA encoding the short isoform of Tkv (42). Transformation
was carried out as described elsewhere (2).
Clonal analysis of omb expression in the
AyGAL4 system.
AyGAL4 designates a transgene
consisting of Actin5C promoter-yeast FLP recombinase target
(FRT)-transcriptional termination signal-yellow+-FRT-GAL4
(28). Larvae carrying both the AyGAL4 and
hsFlp (yeast FLP recombinase gene driven by the
heat shock promoter) transgenes were produced. GAL4-expressing clones
were induced by heat treatment (at 37°C for 30 min) 48 to 72 h
after egg laying, and omb expression was observed 48 h
later (see also the legend to Fig. 6B).
Immunoprecipitation by anti-p-Tyr antibody.
Drosophila
extract preparation and immunoprecipitation methods were essentially as
described previously (29). Three volumes of extraction
buffer were added to flies pulverized in liquid N2.
Anti-phosphotyrosine (anti-p-Tyr) antibody (4G10) was purchased from
Upstate Biotechnology Incorporated. Immunoprecipitates from extracts
equivalent to 25 individuals were loaded in each lane for electrophoresis.
Western blot analysis of Drosophila extracts.
Extracts were prepared in the presence of 4% sodium dodecyl sulfate
(SDS) as described elsewhere (4). Extract from the equivalent of 0.2 individual per lane was loaded for electrophoresis and then subjected to Western blotting. Anti-D-p38b antibody was prepared by immunization of a rabbit with recombinant glutathione S-transferase (GST)-D-p38b fusion protein.
Nucleotide sequence accession number.
The DDBJ accession no.
for D-p38b cDNA is AB006364.
 |
RESULTS |
Identification and characterization of D-p38b.
Mammalian p38 has been shown to complement the
high-osmolarity-sensitive growth phenotype of the budding yeast
hog1
mutant (7, 22). To isolate the cDNA for
the Drosophila homolog of p38, we conducted genetic screens
to isolate suppressors of the hog1
mutation
(36). A total of 16 positive clones were obtained and
assigned to two classes (Fig. 1). The
cDNAs from one class were identical to DJNK (46,
50). cDNAs from the other class were identical to
D-p38b, recently reported to be the Drosophila homolog of p38 (24) based on the genomic sequence deposited by the Berkeley Drosophila Genome Project. We subsequently
carried out hybridization screening with another cDNA library
(8) to obtain a longer D-p38b cDNA clone.
Comparison of the cDNA and genomic sequences revealed that the
D-p38b gene is organized into two exons, although its coding
region is continuous within a single exon (Fig.
2A). The D-p38b locus was
mapped to the 34D region on the second chromosome by in situ
chromosomal hybridization (Fig. 2B), whereas the D-p38a
locus was reported to map to the 95E4-to-95F1 region on the third
chromosome (24). Expression of D-p38b is known to
occur in most of the tissues throughout the Drosophila life
span (1, 24).

View larger version (80K):
[in this window]
[in a new window]
|
FIG. 1.
Complementation of the S. cerevisiae MAPK
hog1 mutant by Drosophila members of the MAPK
superfamily. The D-p38b+ clone clearly complements the
high-osmolarity (0.9 M sorbitol)-sensitive growth phenotype of the
hog1 mutant, while the DJNK+ clone does so
only weakly. The Rl+ clone fails to complement this
phenotype. When the TGY sequence of D-p38b, a putative MAPKK
phosphorylation site, was mutated (T183A and Y185F), complementation
was abolished.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
Exon organization and mapping of the D-p38b
gene. (A) Exon organization of the D-p38b gene. Two exons
are indicated by boxes. The coding region is filled. Nucleotide 1 is
assigned to the 5' end of the longest D-p38b cDNA. (B) In
situ chromosomal hybridization. Salivary gland polytene chromosomes
were derived from the hemizygote of Df(2L)b82a2 which had
lost the region from 34D1 to -2 through 34E1 to -2 (37). The
hybridization signal (arrow) was observed at the 34D region. This
region expands somewhat owing to the compression caused by pairing of
the wild-type chromosome with the deficiency chromosome. The method
used for digoxigenin-labelled in situ hybridizations has been described
previously (2).
|
|
Inhibition of D-p38 function leads to induction of a
dpp-related wing phenotype.
The chromosomal region
around the D-p38b locus has been well characterized
genetically (53). However, the
D-p38b+ transgene was unable to rescue any of
the known mutations mapping to this region [l(2)34Da
(kuz), l(2)34Db, and l(2)34Dc].
Likewise, attempts to isolate a mutant of D-p38b from 3,000 chromosomes mutagenized by ethyl methanesulfonate were unsuccessful.
These failures were possibly due to the functional redundancy of the two p38 homologs. We therefore used methods to interfere with endogenous D-p38(s) in order to investigate its function. A
dominant-negative allele of D-p38b, designated
D-p38bDN, was generated by replacing the Thr-183
of the MAPKK target site with Ala, analogous to the change in ERK2
which produces a dominant-negative allele (44). This
recombinant mutant protein lost its ability to suppress the yeast
hog1
mutant phenotype (Fig. 1).
Expression of D-p38bDN was induced in a wild-type
background by using the GAL4-upstream activation sequence (UAS) system
(6). We isolated two lines which express
D-p38bDN at different levels: D-p38bDN-S
(Strong), which expresses high levels, and D-p38bDN-W
(Weak), which expresses low levels. When two copies of the
D-p38bDN-S transgene were expressed in the wing
by using two copies of the 32B-GAL4 enhancer trap transgene
(6), a certain fraction of adult flies that escaped death
exhibited ectopic vein fragments around the end of the longitudinal
vein L2 and a reduction in the distance between L4 and L5 (Fig.
3B). Both of these features were also
observed with some mutant alleles of dpp (Fig. 3C) and tkv (thick veins [Fig. 3D]), a gene encoding a
type I receptor for Dpp (9, 39, 42, 45). This wing
phenotype was rescued by coexpression of the
D-p38b+ transgene but not by coexpression of a
DJNK+ transgene (1), indicating that
the effect of D-p38bDN expression is specific.
When two copies of the D-p38bDN-S
transgene were weakly expressed in the wing of a dpp mutant
by using one copy of the 32B-GAL4 transgene, the vein
phenotype of dpp was strongly enhanced (Fig. 3E). These
phenotypes suggest the involvement of D-p38(s) in Dpp function in the
early and late stages of wing pattern development. Dpp is known to play
a dual role during wing development, acting as a morphogen (34,
40) and mitogen (14) in the early stage, while
activating vein differentiation in the late stage (13).

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of D-p38bDN on wing phenotype. (A)
Wild-type Canton-S. L2, L3, L4, and L5 indicate the four longitudinal
veins. (B) An individual expressing high levels of
D-p38bDN. The distance between L4 and L5 (double-headed
arrow) is reduced, similar to what is seen in the dpp mutant
(panel C). Ectopic veins around distal L2 (arrow) are reminiscent of
those in various tkv mutants (see panel D) (13, 37,
45). A notched wing margin is occasionally observed with other
dpp alleles (see panel F). (C) An example of a very
hypomorphic dpp allele
(dppd5/dpphr27) (37). (D)
An example of a hypomorphic tkv allele
(tkv7/tkv427). (E) A dpp
mutant expressing moderate levels of D-p38bDN. L4 and L5
were partially fused, and the distance between L2 and L3 was also
reduced, similar to that seen with the severe dpp alleles
(9) (see panel F). (F) An example of a severe dpp
allele (dppd5/dpphr56)
(37).
|
|
Involvement of D-p38b in a Dpp-Tkv signaling pathway leading to
vein formation.
To examine whether D-p38(s) functions in the Dpp
signaling pathway, we tested the genetic interaction between D-p38(s)
and a constitutively active mutant of Tkv (TkvCA), in which
a Gln in the GS domain has been replaced by an acidic residue (34,
40, 52). Two classes of tkvCA
insertions, tkvCA-S (Strong) and
tkvCA-W (Weak), were used. When
tkvCA-S was driven by 71B-GAL4
(6), normal wing venation was severely distorted
and extensive production of fragments of vein material was observed
(Fig. 4A) (13). The
abdominal-cuticle pattern also appeared irregular (1). This
wing phenotype suggested that TkvCA may influence Dpp
action during vein formation. Ectopic coexpression of
dpp+ and tkv+ under the
control of 71B-GAL4 caused similar phenotypes
(1), indicating that these TkvCA-induced
aberrations were indeed the result of an increase in Dpp
signaling. We thus expected that reducing the levels of downstream components would suppress tkvCA. In fact,
reducing the gene dosage of Mothers against dpp
(Mad), a well-documented Dpp-signaling factor (25,
49), by one-half significantly suppressed the
tkvCA wing phenotype (Fig. 4B and G). Similar
phenomena have been reported previously (11, 26).

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of reduced Mad gene dosage, the p38
inhibitor SB03580, and reduced D-p38 gene dosage on the
adult wing phenotype induced by constitutively active Tkv
(TkvCA). (A through F) Adult wing phenotypes. All these
wings are from individuals carrying one copy each of
UAS-tkvCA-S and 71B-GAL4. (A)
Wild-type background for other genes. Incision of wing margins was
frequently observed. (B) Hemizygote for Df(2L)C28
(49) that uncovers the Mad locus. Reduction of
the Mad gene dosage suppresses the
tkvCA wing phenotype. (C) An individual fed a
standard diet supplemented by 120 nM SB203580 (a p38 inhibitor;
Calbiochem/Novabiochem). SB203580 suppresses the
tkvCA wing phenotype. (D) Hemizygote of
Df(3R)crb-F89-4 that uncovers the D-p38a locus.
Reduction of D-p38a gene dosage does not suppress the
tkvCA wing phenotype. (E) Hemizygote of
Df(2L)b82a2 that uncovers the D-p38b locus.
Reduction of D-p38b gene dosage suppresses the
tkvCA wing phenotype. (F) Hemizygote of
Df(2L)b82a2 carrying one copy of
UAS-D-p38b+. Suppression by reduced
D-p38b gene dosage was abrogated by reintroducing the
D-p38b+ transgene. (G) Quantitative
representation. Histograms represent percentages of wings in which L5
is detached from the wing margin.
|
|
We first tested the effect of the imidazole compound SB203580, a p38
inhibitor (
35), on the
tkvCA wing
phenotype. SB203580 has been reported to inhibit both D-p38a
and D-p38b
(
24), and penetration of various imidazole compounds
through
the insect epidermis is well known (
32). Consequently,
exposure of growing larvae to SB203580 resulted in suppression
of the
phenotype (Fig.
4C and G). We further tested whether endogenous
D-p38 genes are involved in the
tkvCA
wing phenotype by reducing endogenous gene dosage using chromosomal
hemizygosity. Interestingly, reduction of
D-p38b suppressed
the
tkvCA wing phenotype (Fig.
4E and G), while
reduction of
D-p38a was
not effective (Fig.
4D and G).
Suppression by reduction of the
D-p38b gene dosage was
abrogated by the introduction of a transgene
for
D-p38b+ (Fig.
4F and G). Thus, the gene within
the deficiency that suppresses
tkvCA is indeed
D-p38b. These results suggest that
D-p38b plays a
major
role in this morphogenetic process, and we focused on this gene
in further
analyses.
When antisense
D-p38b RNA was coexpressed with
Tkv
CA-S, the
tkvCA-S phenotype was
markedly suppressed (Fig.
5B and
G). Four of five
independently
established
D-p38bantisense lines showed
significant suppression (
1). Suppression affected
the
various pleiotropic phenotypes associated with the
tkvCA allele, including wing blade
morphology, abdominal-cuticle morphology,
and wing posture. Similar
suppression of the
tkvCA phenotype was also
achieved by coexpression of D-p38b
DN-W in a
dose-dependent manner (Fig.
5C, D, and G). This suppression
was greater
when D-p38b
DN-S was coexpressed (Fig.
5G). Furthermore,
this suppression was
abrogated by simultaneous coexpression of
D-p38b+ (Fig.
5E and G), demonstrating that
D-p38b
DN and D-p38b
+ competitively sequester
endogenous factors essential to signaling.
These results suggest either
that D-p38b functions downstream
of Tkv or that inhibition of D-p38b
causes a reduction in endogenous
dpp activity. Since the
expression pattern of
dpp in the developing
wing of the
D-p38bDN-S producer was found to be
indistinguishable from that of the wild
type (
1), and
reduction in the gene dosage of
dpp was not effective
in
suppressing the
tkvCA phenotype (Fig.
5F and G),
we conclude that D-p38b does not affect
Dpp production per se but
rather acts as a downstream component
of the Dpp-Tkv signaling pathway,
operating late in wing development.
The fact that the weak phenotype of
tkvCA-W was significantly enhanced by
D-p38b
+ (Fig.
5G) is also consistent with this conclusion.
In contrast,
attempts to interfere with the function of DJNK, such as
by coexpression
of DJNK
DN (T181A nonactivatable mutant) or
generation of chromosomal hemizygosity,
did not result in suppression
of the
tkvCA phenotype (Fig.
5G). Thus, the role
of D-p38b in Dpp signaling
appears to be specific. Moreover, expression
of D-p38b
DN did not have any significant effect on the wing
phenotypes caused
by expression of other dominant active receptors such
as DER (
ElpB1 [
37]) or Notch
(
Ax1 [
37]) (
1),
further indicating the specificity of D-p38b
function for Dpp
signaling.

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 5.
Effects of altering D-p38b function and reducing DJNK,
Dpp, and Tkv functions on the wing phenotypes caused by either
UAS-tkvCA-W (W) or
UAS-tkvCA-S (S) driven by 71B-GAL4.
(A through F) Adult wing phenotypes. All these wings are from
individuals carrying one copy each of
UAS-tkvCA-S and 71B-GAL4. (A)
Wild-type background for other genes. (B) An individual carrying one
copy of UAS-D-p38bantisense.
D-p38bantisense suppresses the
tkvCA wing phenotype. (C and D) Individuals
carrying one copy (C) or two copies (D) of
UAS-D-p38bDN-W. D-p38bDN suppresses
the tkvCA wing phenotype in a dose-response
manner. (E) An individual carrying two copies of
UAS-D-p38bDN-W together with one copy of
UAS-D-p38b+. Suppression by
D-p38bDN was abrogated by coexpression of
D-p38b+. (F) Heterozygote of
dppd8 (37). Reduction of the
dpp gene dosage does not suppress the
tkvCA wing phenotype. (G) Quantitative
representation. Histograms represent percentages of wings in which L5
is detached from the wing margin. ++, two introduced copies of the
transgenes. Df(DJNK), Df(2L)flp147E (46,
50).
|
|
Effect of D-p38b on Tkv-dependent omb
transcription.
To examine the involvement of D-p38b in the Dpp
signaling pathway, we tested the effect of D-p38b on omb
transcription. The omb (optomotor-blind) gene
encodes a T-box family transcription factor, and its expression in the
wing imaginal disc is dependent on early Dpp-Tkv signaling (20,
34, 40). In the wing discs of
UAS-tkvCA-S/69B-GAL4 (6) individuals,
omb expression domain is greatly expanded and overgrowth of
the disc is evident (Fig. 6A, panel b),
as previously reported (40). Expression of
D-p38bDN or
D-p38bantisense markedly suppressed both
omb expression and disc overgrowth (Fig. 6A, panel c or d,
respectively). Induction of omb in the
tkvCA-expressing clones in regions outside those
where dpp is expressed was also inhibited by coexpression of
D-p38bDN (Fig. 6B), consistent with the
possibility that D-p38b functions downstream of Tkv. Furthermore, while
D-p38bDN slightly affected omb expression in a
tkv+ genetic background (1), the wing
phenotype of a hypomorphic omb allele was clearly enhanced
by expression of D-p38bDN or
D-p38bantisense (Fig.
7), as observed in the wing phenotype of
the severe omb alleles such as
omb3198 and omb282
(20, 34). These results suggest that D-p38b is also involved in early Dpp-Tkv signaling in wing development to activate
omb transcription.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 6.
D-p38b regulates early Dpp-Tkv signaling-dependent
omb expression in the wing disc. (A) The omb
expression pattern visualized by a lacZ reporter,
ombP1 (51). Anterior is to the top
and dorsal to the left. (a) ombP1/+;
69B-GAL4/+ (control). (b) ombP1/+;
69B-GAL4/UAS-tkvCA-S. TkvCA
induces ectopic expression of omb (arrow) and overgrowth.
This photograph is reduced to 75% the size of the others. (c)
ombP1/UAS-D-p38bDN-W;
69B-GAL4/UAS-tkvCA-S. (d)
ombP1/UAS-D-p38bantisense;
69B-GAL4/UAS-tkvCA-S. Expression of either
D-p38bDN or
D-p38bantisense reduced
TkvCA-induced ectopic omb expression (arrows)
and overgrowth (c or d, respectively). (B)
D-p38bDN-expressing clones generated outside the domain in
which dpp is expressed display reduced sensitivity of
omb induction to TkvCA. Note that dpp
expression at this stage in the wing disc lies in a narrow belt just
anterior to the anteroposterior boundary (20, 24). Clones of
cells that expressed various UAS-transgenes under the control of
Actin5C-GAL4 were generated by the flp-out technique and
marked by the presence of green fluorescent protein (GFP)
(28) (a and d, green). omb expression was
revealed by staining with an antibody raised against -galactosidase
(Promega) (b and e, red). (a through c) Wing disc-carrying clones
expressing both D-p38b+ and
tkvCA as controls (hsFlp/ombP1
UAS-D-p38b+; AyGAL4 UAS-GFP/+;
UAS-tkvCA-S/+). (d through f) Wing disc-carrying
clones expressing both D-p38bDN and
tkvCA (hsFlp/ombP1
UAS-D-p38bDN-S; AyGAL4 UAS-GFP/+;
UAS-tkvCA-S/+). (c and f) Superimposed images.
|
|

View larger version (96K):
[in this window]
[in a new window]
|
FIG. 7.
Enhancement of ombbi by
D-p38bDN or by
D-p38bantisense. (A) A wing of an
ombbi/Y male. Arrows indicate the aberrations
typically observed: fusion of veins at the base of the wing and small
notching at the wing tip. (B) A wing of an ombbi
individual expressing D-p38bantisense
(ombbi/Y;
UAS-D-p38bantisense/69B-GAL4). (C and D) Wings
of ombbi individuals expressing
D-p38bDN weakly (ombbi
UAS-D-p38bDN-W/Y; 69B-GAL4/+) (C) or
strongly (ombbi UAS-D-p38bDN-S/Y;
69B-GAL4/+) (D). Arrows point to the
ombbi phenotypes.
|
|
D-p38 is activated by Tkv signaling in vivo.
To investigate
whether D-p38b is activated by Tkv signaling, we conducted a
preliminary biochemical characterization of D-p38b. Immediately after
heat treatment of flies, the amount of D-p38b immunoprecipitated by
anti-p-Tyr antibody was found to increase considerably (Fig.
8A), demonstrating that D-p38b is
tyrosine phosphorylated following heat shock, like mammalian p38
(12, 33). The site of tyrosine phosphorylation was expected
to be in the "activation loop" region recognized by MAPKK, as is
the case in mammalian p38 (12, 33). Thus, we tested whether
an anti-phospho-p38 (anti-p-p38) antibody (New England Biolabs, Inc.) raised against a phosphorylated peptide from the activation loop of
mammalian p38 could cross-react with D-p38b (Fig. 8B). This anti-p-p38
antibody detected a protein with a calculated size of 42 kDa whose
amount increased immediately after heat shock (Fig. 8B, left half).
This protein was also more abundant in the flies overproducing D-p38b
regardless of heat treatment (Fig. 8B, right half). Therefore, we
concluded that anti-p-p38 can cross-react with the phosphorylated from
of D-p38b and can be used to assay recombinant D-p38b phosphorylation
in vitro (Fig. 8C). Treatment of D-p38b with recombinant human MKK6
(38), a MAPKK which activates p38, caused a marked increase
in the level of D-p38b, as detected with anti-p-Tyr and anti-p-p38
antibodies, and a drastic increase in the level of D-p38-dependent
phosphorylation of recombinant human activating transcription factor 2 (ATF2; Santa Cruz Biotechnology), a physiological substrate for
mammalian p38 (21). The correlation between the
phosphorylation state and kinase activity of D-p38b indicates that the
anti-p-p38 antibody recognizes the active form of D-p38b. This allowed
activation of D-p38b by TkvCA to be examined in vivo. The
amount of active D-p38b was found to be slightly but significantly
higher in larvae carrying UAS-tkvCA and
71B-GAL4 relative to that in wild-type Canton-S larvae (Fig. 8D). However, it has been reported that D-p38a protein expressed in
yeast, which was presumed to have the same molecular mass as D-p38b, is
also recognized by anti-p-p38 antibody (23). It is therefore
possible that D-p38b, or both D-p38's, may be activated by Tkv
signaling in vivo.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 8.
Phosphorylation and activation of D-p38b. (A) D-p38b is
tyrosine phosphorylated after heat shock. Extracts from adult flies
left untreated or treated with heat (37°C for 1 h) were
immunoprecipitated (IP) with anti-p-Tyr antibody ( -p-Tyr) and
immunoblotted with anti-D-p38b antibody after separation by
SDS-polyacrylamide agarose gel electrophoresis (PAGE) (upper panel).
Total extracts were also immunoblotted with anti-D-p38b antibody (lower
panel). In this experiment, flies carrying one copy each of
UAS-D-p38b+ and hs-GAL4
(6) were used to facilitate detection. The total amount of
D-p38b did not change immediately after heat shock. The basal activity
of the heat shock promoter was sufficient to achieve constitutive
expression of GAL4; thus, D-p38 was overexpressed even in the absence
of heat treatment. (B) Anti-p-p38 antibody recognizes phosphorylated
D-p38b in fly extract. Flies harboring both
UAS-D-p38b+ and hs-GAL4 (right half)
or only hs-GAL4 (left half) were heat shocked as described
above, and extracts were immunoblotted with either anti-p-p38 or
anti-D-p38b antibody after separation by SDS-PAGE. The intensities of
bands recognized by anti-p-p38 increased as a result of either heat
treatment or D-p38b overexpression. (C) The phosphorylation level of
D-p38b correlates with its enzymatic activity. Recombinant D-p38b
protein was pretreated with recombinant MKK6 in the presence of cold
ATP. Then ATF2 and [ -32P]ATP were added to aliquots of
reaction mixtures, and incubation was continued. The resulting mixtures
were resolved by SDS-PAGE and subjected to autoradiography for
detection of kinase activities (top panel) or to immunoblotting with
anti-p-Tyr and anti-p-p38 antibodies (two middle panels). The bottom
panel represents the gel stained with Coomassie brilliant blue (CBB).
The kinase assay method used has been described elsewhere
(30). (D) Activation of D-p38(s) by TkvCA.
Extracts from larvae of Canton-S (wild type) or from larvae carrying
two copies each of UAS-tkvCA-S and
71B-GAL4 were resolved by SDS-PAGE and immunoblotted with
anti-p-p38 or anti-D-p38b antibody.
|
|
 |
DISCUSSION |
To investigate the role of the D-p38b gene in
development, we used reverse genetic techniques. Our genetic analyses
showed that D-p38b is integrally involved in Dpp signaling in the
process of wing morphogenesis. Various manipulations which interfere
with D-p38b function enhanced or suppressed the phenotypes caused by decreased or increased Dpp signaling, respectively. However, the present study did not elucidate any function of D-p38b in normal Dpp
signaling; rather, its effects were apparent only when Dpp signaling
was enhanced or inhibited. For example, D-p38bDN slightly
affected omb expression in a tkv+
background but clearly suppressed it in a tkvCA
background. Thus, it is possible that D-p38 is involved in unusual Dpp
signaling events, consistent with the known role of mammalian p38 as an
emergency signaling factor.
D-p38b and upstream kinases can be involved in the Dpp signaling
pathway.
Both D-p38a and D-p38b were reported to be activated by
D-MKK3, a MAPKK (24). Thus, it is likely that D-p38 is part
of a kinase cascade similar to the mammalian p38 cascade. In fact, genetic manipulation of D-MKK3 function has revealed an interaction with Dpp signaling similar to that found here for D-p38b
(1). However, a corresponding MAPKKK functioning in the
D-p38 cascade has yet to be identified. A mammalian member of the
MAPKKK family, TAK1 (TGF-
-activated kinase 1), has been reported to
mediate signals elicited by TGF-
superfamily members through
activation of MKK3 (a MAPKK), MKK6, and p38 (38, 54). The
activation of D-p38b by TkvCA correlates with that of p38
by TGF-
stimulus (38). Thus, we currently hypothesize
that a D-p38b cascade exists which can be involved in Dpp signaling and
which includes D-MKK3 and a homolog of TAK1.
The signaling hierarchy involving D-p38b in wing disc morphogenesis
is different from that of DJNK in embryonic dorsal closure.
p38 is
known to share many characteristics with JNK (12, 33), such
as activation by various stress-inducing and inflammatory stimuli. In
Drosophila, mutations in DJNK (46, 50) and its activator MAPKK Hemipterous (Hep [18]) cause a
"dorsal open phenotype," reminiscent of that observed in
dpp and tkv mutants. It is also known that the
DJNK signal regulates dpp expression in the leading-edge
cells during embryonic dorsal closure (19, 27, 47). However,
our mosaic analysis shows that the suppression of
tkvCA by D-p38bDN occurs even in
cells which do not produce Dpp (Fig. 6B). This indicates that, in
contrast to the case of dorsal closure, the MAPK functioning in the
wing disc morphogenetic pathway, i.e., D-p38b, acts downstream of Tkv.
The role of D-p38b proposed here may be more analogous to that of
mammalian JNK, which also functions as a downstream component of the
TGF-
and Smad (mammalian homolog of Mad) signaling pathways in the
mammalian cultured cell line MDCK (3).
Possible relationship of the D-p38b cascade and other signaling
factors.
A Dpp-signaling factor, Mad, is known to be directly
phosphorylated by Tkv and then migrates into the nucleus, where it
functions as a DNA-binding transcriptional factor (25). It
is unclear at present if there is any functional interaction between
Mad and D-p38b. While Mad is directly phosphorylated by Tkv
(25), the activation of D-p38 by TkvCA may be
indirect. Alternatively, it is possible that one or more transcription
factors functioning in the Dpp response require prior phosphorylation
mediated by the D-p38 cascade, a process which is regulated
independently of Tkv. In fact, one of the mammalian MAPKs, ERK, which
is regulated independently of the BMP (a mammalian homolog of Dpp)
signaling pathway and activated by the EGF signaling pathway, is known
to phosphorylate Smad1 and prevent its nuclear localization
(31). One class of transcription factors which might
function downstream of D-p38 is the ATF-cyclic AMP responsive element
binding protein (CREB) family, members of which are known to be targets
for the p38 cascade (21). For example, Mad and ATF-CREB
might interact as components in a transcriptional activator complex
which induce expression of Dpp signaling target genes. Correspondingly,
a CREB binding site has been reported to mediate the response to Dpp
signaling during Drosophila endoderm induction (15). Although we have not yet determined whether D-p38(s)
is involved in Dpp-regulated endoderm induction, we know that the function of D-p38b in the Dpp response is not restricted to the wing
because we have observed that forced (by use of a constitutive GAL4
driver) expression of TkvCA throughout the body leads to
D-p38b activation in regions outside the wing (1). In
addition, interfering with D-p38b also suppresses the abdominal
phenotype induced by TkvCA, as mentioned above. Further
examination of the extent of the functional relationship between D-p38
and Dpp signaling in various aspects of Drosophila
development should be useful in identifying targets of D-p38 in Dpp signaling.
 |
ACKNOWLEDGMENTS |
We thank Karin Ekstrom, Shigeo Hayashi, Yasushi Hiromi, Kathy
Matthews, Shigeru Morimura, Gert O. Pflugfelder, and Tetsuya Tabata for
providing fly stocks, Nicholas H. Brown and Patrick H. O'Farrell for
cDNA libraries, Won-Jae Lee and Norbert Perrimon for plasmid DNA,
Masatoshi Hagiwara for recombinant MKK6 protein, and Yutaka Inaguma,
Kanefusa Kato, Michael B. O'Connor, Akira Mizoguchi, Eisuke Nishida,
and Masamitsu Yamaguchi for technical advice. We are also grateful to
Marc Lamphier, Enrique Martín-Blanco, Shin Sugiyama, Tetsuya
Tabata, and Takashi Takabatake for advice on the manuscript and to Kana
Dohmoto and Tomiko Tsuboi for technical assistance.
This work was supported by grants from The Kurata Foundation, The
Ministry of Education, Science, Sports, and Culture of Japan, and the
Japan Science and Technology Corporation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratory of
Developmental Biology, Division of Biological Science, Graduate School of Science, Nagoya University, Chikusa-ku, Nagoya 464-8602, Japan. Phone: 81-52-789-5039. Fax: 81-52-789-2511. E-mail:
adachi{at}bio.nagoya-u.ac.jp.
 |
REFERENCES |
| 1.
| Adachi-Yamada, T. Unpublished data.
|
| 2.
|
Ashburner, M.
1989.
Drosophila, a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 3.
|
Atfi, A.,
M. Buisine,
A. Mazars, and C. Gespach.
1997.
Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor- through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway.
J. Biol. Chem.
272:24731-24734[Abstract/Free Full Text].
|
| 4.
|
Biggs, W. H., III,
K. H. Zavitz,
B. Dickson,
A. van der Straten,
D. Brunner,
E. Hafen, and S. L. Zipursky.
1994.
The Drosophila rolled locus encodes a MAP kinase required in the sevenless signal transduction pathway.
EMBO J.
13:1628-1636[Medline].
|
| 5.
|
Blumer, K. J., and G. L. Johnson.
1994.
Diversity in function and regulation of MAP kinase pathways.
Trends Biochem. Sci.
19:236-240[Medline].
|
| 6.
|
Brand, A. H., and N. Perrimon.
1993.
Targeted gene expression as a means of altering cell fates and generating dominant phenotype.
Development
118:401-415[Abstract].
|
| 7.
|
Brewster, J. L.,
T. de Valoir,
N. D. Dwyer,
E. Winter, and M. C. Gustin.
1993.
An osmosensing signal transduction pathway in yeast.
Science
259:1760-1763[Abstract/Free Full Text].
|
| 8.
|
Brown, N. H., and F. C. Kafatos.
1988.
Functional cDNA libraries from Drosophila embryo.
J. Mol. Biol.
203:425-437[Medline].
|
| 9.
|
Brummel, T. J.,
V. Twombly,
G. Marqués,
J. L. Wrana,
S. J. Newfeld,
L. Attisano,
J. Massagué,
M. B. O'Connor, and W. M. Gelbart.
1994.
Characterization and relationship of Dpp receptors encoded by the saxophone and thick veins genes in Drosophila.
Cell
78:251-261[Medline].
|
| 10.
|
Brunner, D.,
N. Oellers,
J. Szabad,
W. H. Biggs III,
S. L. Zipursky, and E. Hafen.
1994.
A gain-of-function mutation in Drosophila MAP kinase activates multiple receptor tyrosine kinase signaling pathways.
Cell
76:875-888[Medline].
|
| 11.
|
Das, P.,
L. L. Maduzia,
H. Wang,
A. L. Finelli,
S.-H. Cho,
M. M. Smith, and R. W. Padgett.
1998.
The Drosophila gene Medea demonstrates the requirement for different classes of Smads in dpp signaling.
Development
125:1519-1528[Abstract].
|
| 12.
|
Davis, R. J.
1994.
MAPKs: new JNK expands the group.
Trends Biochem. Sci.
19:470-473[Medline].
|
| 13.
|
de Celis, J. F.
1997.
Expression and function of decapentaplegic and thick veins during the differentiation of the veins in the Drosophila wing.
Development
124:1007-1018[Abstract].
|
| 14.
|
Edgar, B. A., and C. F. Lehner.
1996.
Developmental control of cell cycle regulators: a fly's perspective.
Science
274:1646-1652[Abstract/Free Full Text].
|
| 15.
|
Eresh, S.,
J. Riese,
D. B. Jackson,
D. Bohmann, and M. Bienz.
1997.
A CREB-binding site as a target for decapentaplegic signalling during Drosophila endoderm induction.
EMBO J.
16:2014-2022[Medline].
|
| 16.
|
Gabay, L.,
R. Seger, and B.-Z. Shilo.
1997.
In situ activation pattern of Drosophila EGF receptor pathway during development.
Science
277:1103-1106[Abstract/Free Full Text].
|
| 17.
|
Gabay, L.,
R. Seger, and B.-Z. Shilo.
1997.
MAP kinase in situ activation atlas during Drosophila embryogenesis.
Development
124:3535-3541[Abstract].
|
| 18.
|
Glise, B.,
H. Bourbon, and S. Noselli.
1995.
hemipterous encodes a novel Drosophila MAP kinase kinase, required for epithelial cell sheet movement.
Cell
83:451-461[Medline].
|
| 19.
|
Glise, B., and S. Noselli.
1997.
Coupling of Jun amino-terminal kinase and Decapentaplegic signaling pathways in Drosophila morphogenesis.
Genes Dev.
11:1738-1747[Abstract/Free Full Text].
|
| 20.
|
Grimm, S., and G. O. Pflugfelder.
1996.
Control of the gene optomotor-blind in Drosophila wing development by decapentaplegic and wingless.
Science
271:1601-1604[Abstract].
|
| 21.
|
Gupta, S.,
D. Campbell,
B. Dérijard, and R. J. Davis.
1995.
Transcription factor ATF2 regulation by the JNK signal transduction pathway.
Science
267:389-393[Abstract/Free Full Text].
|
| 22.
|
Han, J.,
J.-D. Lee,
L. Bibbs, and R. J. Ulevitch.
1994.
A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.
Science
265:808-811[Abstract/Free Full Text].
|
| 23.
|
Han, S.-J.,
K.-Y. Choi,
P. T. Brey, and W.-J. Lee.
1998.
Molecular cloning and characterization of a Drosophila p38 mitogen-activated protein kinase.
J. Biol. Chem.
279:369-374.
|
| 24.
|
Han, Z. S.,
H. Enslen,
X. Hu,
X. Meng,
I.-H. Wu,
T. Barrett,
R. J. Davis, and Y. T. Ip.
1998.
A conserved p38 mitogen-activated protein kinase pathway regulates Drosophila immunity gene expression.
Mol. Cell. Biol.
18:3527-3539[Abstract/Free Full Text].
|
| 25.
|
Heldin, C.-H.,
K. Miyazono, and P. ten Dijke.
1997.
TGF- signalling from cell membrane to nucleus through SMAD proteins.
Nature
390:465-471[Medline].
|
| 26.
|
Hoodless, P. A.,
T. Haerry,
S. Abdollah,
M. Stapleton,
M. B. O'Connor,
L. Attisano, and J. L. Wrana.
1996.
MADR1, a MAD-related protein that functions in BMP2 signaling pathways.
Cell
85:489-500[Medline].
|
| 27.
|
Hou, X. S.,
E. S. Goldstein, and N. Perrimon.
1997.
Drosophila Jun relays the Jun amino-terminal kinase signal transduction pathway to the Decapentaplegic signal transduction pathway in regulating epithelial cell sheet movement.
Genes Dev.
11:1728-1737[Abstract/Free Full Text].
|
| 28.
|
Ito, K.,
W. Awano,
K. Suzuki,
Y. Hiromi, and D. Yamamoto.
1997.
The Drosophila mushroom body is a quadruple structure of clonal units each of which contains a virtually identical set of neurons and glial cells.
Development
124:761-771[Abstract].
|
| 29.
|
Kosako, H.,
Y. Gotoh,
S. Matsuda,
M. Ishikawa, and E. Nishida.
1992.
Xenopus MAP kinase activator is a serine/threonine/tyrosine kinase activated by threonine phosphorylation.
EMBO J.
11:2903-2908[Medline].
|
| 30.
|
Kosako, H.,
E. Nishida, and Y. Gotoh.
1993.
cDNA cloning of MAP kinase kinase reveals kinase cascade pathways in yeasts to vertebrates.
EMBO J.
12:787-794[Medline].
|
| 31.
|
Kretzschmar, M.,
J. Doody, and J. Massagué.
1997.
Opposing BMP and EGF signalling pathways converge on the TGF- family mediator Smad1.
Nature
389:618-622[Medline].
|
| 32.
|
Kuwano, E.,
R. Takeya, and M. Eto.
1985.
Synthesis and anti-juvenile hormone activity of 1-substituted-5-[(E)-2,6-dimethyl-1,5-heptadienyl]imidazoles.
Agric. Biol. Chem.
49:483-486.
|
| 33.
|
Kyriakis, J. M., and J. Avruch.
1996.
Protein kinase cascades activated by stress and inflammatory cytokines.
Bioessays
18:567-577[Medline].
|
| 34.
|
Lecuit, T.,
W. J. Brrok,
M. Ng,
M. Calleja,
H. Sun, and S. M. Cohen.
1996.
Two distinct mechanisms for long-range patterning by Decapentaplegic in the Drosophila wing.
Nature
381:387-393[Medline].
|
| 35.
|
Lee, J. C.,
J. T. Laydon,
P. C. McDonnell,
T. F. Gallagher,
S. Kumar,
D. Green,
D. McNulty,
M. J. Blumenthal,
J. R. Heys,
S. W. Landvatter,
J. E. Stickler,
M. M. McLaughlin,
I. R. Siemens,
S. M. Fisher,
G. P. Livi,
J. R. White,
J. L. Adams, and P. R. Young.
1994.
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis.
Nature
372:739-746[Medline].
|
| 36.
|
Léopold, P., and P. H. O'Farrell.
1991.
An evolutionarily conserved cyclin homolog from Drosophila rescues yeast deficient in G1 cyclins.
Cell
66:1207-1216[Medline].
|
| 37.
|
Lindsley, D. L., and G. G. Zimm.
1992.
The genome of Drosophila melanogaster.
Academic Press, Inc., San Diego, Calif.
|
| 38.
|
Moriguchi, T.,
N. Kuroyanagi,
K. Yamaguchi,
Y. Gotoh,
K. Irie,
T. Kano,
K. Shirakabe,
Y. Muro,
H. Shibuya,
K. Matsumoto,
E. Nishida, and M. Hagiwara.
1996.
A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3.
J. Biol. Chem.
271:13675-13679[Abstract/Free Full Text].
|
| 39.
|
Nellen, D.,
M. Affolter, and K. Basler.
1994.
Receptor serine/threonine kinases implicated in the control of Drosophila body pattern by decapentaplegic.
Cell
78:225-237[Medline].
|
| 40.
|
Nellen, D.,
R. Burke,
G. Struhl, and K. Basler.
1996.
Direct and long-range action of DPP morphogen gradient.
Cell
85:357-368[Medline].
|
| 41.
|
Nishida, E., and Y. Gotoh.
1993.
The MAP kinase cascade is essential for diverse signal transduction pathways.
Trends Biochem. Sci.
18:128-131[Medline].
|
| 42.
|
Okano, H.,
S. Yoshikawa,
A. Suzuki,
N. Ueno,
M. Kaizu,
M. Okabe,
T. Takahashi,
M. Matsumoto,
K. Sawamoto, and K. Mikoshiba.
1994.
Cloning of a Drosophila melanogaster homologue of the mouse type-I bone morphogenetic protein-2/-4 receptor: a potential decapentaplegic receptor.
Gene
148:203-209[Medline].
|
| 43.
|
Padgett, R. W.,
D. D. St Johnston, and W. M. Gelbart.
1987.
A transcript from Drosophila pattern gene predicts a protein homologous to the transforming growth factor- family.
Nature
325:81-84[Medline].
|
| 44.
|
Pagès, G.,
P. Lenormand,
G. L'Allemain,
J.-C. Chambard,
S. Meloche, and J. Pouysségur.
1993.
Mitogen-activated protein kinase p42mapk and p44mapk are required for fibroblast proliferation.
Proc. Natl. Acad. Sci. USA
90:8309-8323.
|
| 45.
|
Penton, A.,
T. Chen,
K. Staehling-Hampton,
J. L. Wrana,
L. Attisano,
J. Szidonya,
J. A. Cassill,
J. Massagué, and F. M. Hoffman.
1994.
Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor.
Cell
78:239-250[Medline].
|
| 46.
|
Riesgo-Escovar, J. R.,
M. Jenni,
A. Fritz, and E. Hafen.
1996.
The Drosophila Jun-N-terminal kinase is required for cell morphogenesis but not for Djun-dependent cell fate specification in the eye.
Genes Dev.
10:2759-2768[Abstract/Free Full Text].
|
| 47.
|
Riesgo-Escovar, J. R., and E. Hafen.
1997.
Drosophila Jun kinase regulates expression of decapentaplegic via the ETS-domain protein Aop and the AP-1 transcription factor Djun during dorsal closure.
Genes Dev.
11:1717-1727[Abstract/Free Full Text].
|
| 48.
|
Schulze, K. L., and H. J. Bellen.
1996.
Drosophila syntaxin is required for cell viability and may function in membrane formation and stabilization.
Genetics
144:1713-1724[Abstract].
|
| 49.
|
Sekelsky, J. J.,
S. J. Newfeld,
L. A. Raftery,
E. H. Chartoff, and W. M. Gelbart.
1995.
Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster.
Genetics
139:1347-1358[Abstract].
|
| 50.
|
Sluss, H. K.,
Z. Han,
T. Barrett,
R. J. Davis, and Y. T. Ip.
1996.
A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila.
Genes Dev.
10:2745-2758[Abstract/Free Full Text].
|
| 51.
|
Sun, Y. H.,
C.-J. Tsai,
M. M. Green,
J.-L. Chao,
C.-T. Yu,
T. J. Jaw,
J.-Y. Yeh, and V. N. Bolshakov.
1995.
white as a reporter gene to detect transcriptional silencers specifying position-specific gene expression during Drosophila melanogaster eye development.
Genetics
141:1075-1086[Abstract].
|
| 52.
|
Wieser, R.,
J. L. Wrana, and J. Massagué.
1995.
GS domain mutations that constitutively activate T R-I, the downstream signaling component in the TGF- receptor complex.
EMBO J.
14:2199-2208[Medline].
|
| 53.
|
Woodruff, R. C., and M. Ashburner.
1979.
The genetics of a small autosomal region of Drosophila melanogaster containing the structural gene for alcohol dehydrogenase. II. Lethal mutations in the region.
Genetics
92:133-149[Abstract/Free Full Text].
|
| 54.
|
Yamaguchi, K.,
K. Shirakabe,
H. Shibuya,
K. Irie,
I. Oishi,
N. Ueno,
T. Taniguchi,
E. Nishida, and K. Matsumoto.
1995.
Identification of a member of the MAPKKK family as a potential mediator of TGF- signal transduction.
Science
270:2008-2011[Abstract/Free Full Text].
|
Molecular and Cellular Biology, March 1999, p. 2322-2329, Vol. 19, No. 3
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Machado, R. D., Eickelberg, O., Elliott, C. G., Geraci, M. W., Hanaoka, M., Loyd, J. E., Newman, J. H., Phillips, J. A. III, Soubrier, F., Trembath, R. C., Chung, W. K.
(2009). Genetics and genomics of pulmonary arterial hypertension.. J Am Coll Cardiol
54: S32-S42
[Abstract]
[Full Text]
-
Jaramillo, M. S., Lovato, C. V., Baca, E. M., Cripps, R. M.
(2009). Crossveinless and the TGF{beta} pathway regulate fiber number in the Drosophila adult jump muscle. Development
136: 1105-1113
[Abstract]
[Full Text]
-
Shimizu, H., Shimoda, M., Yamaguchi, T., Seong, K.-H., Okamura, T., Ishii, S.
(2008). Drosophila ATF-2 Regulates Sleep and Locomotor Activity in Pacemaker Neurons. Mol. Cell. Biol.
28: 6278-6289
[Abstract]
[Full Text]
-
Babcock, D. T., Brock, A. R., Fish, G. S., Wang, Y., Perrin, L., Krasnow, M. A., Galko, M. J.
(2008). Circulating blood cells function as a surveillance system for damaged tissue in Drosophila larvae. Proc. Natl. Acad. Sci. USA
105: 10017-10022
[Abstract]
[Full Text]
-
Balakireva, M., Rosse, C., Langevin, J., Chien, Y.-c., Gho, M., Gonzy-Treboul, G., Voegeling-Lemaire, S., Aresta, S., Lepesant, J.-A., Bellaiche, Y., White, M., Camonis, J.
(2006). The Ral/Exocyst Effector Complex Counters c-Jun N-Terminal Kinase-Dependent Apoptosis in Drosophila melanogaster. Mol. Cell. Biol.
26: 8953-8963
[Abstract]
[Full Text]
-
Janody, F., Treisman, J. E.
(2006). Actin capping protein {alpha} maintains vestigial-expressing cells within the Drosophila wing disc epithelium. Development
133: 3349-3357
[Abstract]
[Full Text]
-
Sano, Y., Akimaru, H., Okamura, T., Nagao, T., Okada, M., Ishii, S.
(2005). Drosophila Activating Transcription Factor-2 Is Involved in Stress Response via Activation by p38, but Not c-Jun NH2-Terminal Kinase. Mol. Biol. Cell
16: 2934-2946
[Abstract]
[Full Text]
-
Cha, G.-H., Cho, K. S., Lee, J. H., Kim, M., Kim, E., Park, J., Lee, S. B., Chung, J.
(2003). Discrete Functions of TRAF1 and TRAF2 in Drosophila melanogaster Mediated by c-Jun N-Terminal Kinase and NF-{kappa}B-Dependent Signaling Pathways. Mol. Cell. Biol.
23: 7982-7991
[Abstract]
[Full Text]
-
Edlund, S., Bu, S., Schuster, N., Aspenstrom, P., Heuchel, R., Heldin, N.-E., ten Dijke, P., Heldin, C.-H., Landstrom, M.
(2003). Transforming Growth Factor-beta 1 (TGF-beta )-induced Apoptosis of Prostate Cancer Cells Involves Smad7-dependent Activation of p38 by TGF-beta -activated Kinase 1 and Mitogen-activated Protein Kinase Kinase 3. Mol. Biol. Cell
14: 529-544
[Abstract]
[Full Text]
-
Bakin, A. V., Rinehart, C., Tomlinson, A. K., Arteaga, C. L.
(2002). p38 mitogen-activated protein kinase is required for TGF{beta}-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci.
115: 3193-3206
[Abstract]
[Full Text]
-
Ferguson, C. M., Schwarz, E. M., Reynolds, P. R., Puzas, J. E., Rosier, R. N., O'Keefe, R. J.
(2000). Smad2 and 3 Mediate Transforming Growth Factor-{beta}1-Induced Inhibition of Chondrocyte Maturation. Endocrinology
141: 4728-4735
[Abstract]
[Full Text]
-
Fahmi, H., Cochet, C., Hmama, Z., Opolon, P., Joab, I.
(2000). Transforming Growth Factor Beta 1 Stimulates Expression of the Epstein-Barr Virus BZLF1 Immediate-Early Gene Product ZEBRA by an Indirect Mechanism Which Requires the MAPK Kinase Pathway. J. Virol.
74: 5810-5818
[Abstract]
[Full Text]
-
Takatsu, Y., Nakamura, M., Stapleton, M., Danos, M. C., Matsumoto, K., O'Connor, M. B., Shibuya, H., Ueno, N.
(2000). TAK1 Participates in c-Jun N-Terminal Kinase Signaling during Drosophila Development. Mol. Cell. Biol.
20: 3015-3026
[Abstract]
[Full Text]
-
Massagué, J., Chen, Y.-G.
(2000). Controlling TGF-beta signaling. Genes Dev.
14: 627-644
[Full Text]
-
Miyazono, K
(2000). Positive and negative regulation of TGF-beta signaling. J. Cell Sci.
113: 1101-1109
[Abstract]
-
Hanafusa, H., Ninomiya-Tsuji, J., Masuyama, N., Nishita, M., Fujisawa, J.-i., Shibuya, H., Matsumoto, K., Nishida, E.
(1999). Involvement of the p38 Mitogen-activated Protein Kinase Pathway in Transforming Growth Factor-beta -induced Gene Expression. J. Biol. Chem.
274: 27161-27167
[Abstract]
[Full Text]
-
Ashburner, M., Misra, S., Roote, J., Lewis, S. E., Blazej, R., Davis, T., Doyle, C., Galle, R., George, R., Harris, N., Hartzell, G., Harvey, D., Hong, L., Houston, K., Hoskins, R., Johnson, G., Martin, C., Moshrefi, A., Palazzolo, M., Reese, M. G., Spradling, A., Tsang, G., Wan, K., Whitelaw, K., Kimmel, B., Celniker, S., Rubin, G. M.
(1999). An Exploration of the Sequence of a 2.9-Mb Region of the Genome of Drosophila melanogaster: The Adh Region. Genetics
153: 179-219
[Abstract]
[Full Text]
-
Peron, P., Rahmani, M., Zagar, Y., Durand-Schneider, A.-M., Lardeux, B., Bernuau, D.
(2001). Potentiation of Smad Transactivation by Jun Proteins during a Combined Treatment with Epidermal Growth Factor and Transforming Growth Factor-beta in Rat Hepatocytes. ROLE OF PHOSPHATIDYLINOSITOL 3-KINASE-INDUCED AP-1 ACTIVATION. J. Biol. Chem.
276: 10524-10531
[Abstract]
[Full Text]
-
Sasaki, A., Masuda, Y., Ohta, Y., Ikeda, K., Watanabe, K.
(2001). Filamin Associates with Smads and Regulates Transforming Growth Factor-beta Signaling. J. Biol. Chem.
276: 17871-17877
[Abstract]
[Full Text]
-
Chipuk, J. E., Bhat, M., Hsing, A. Y., Ma, J., Danielpour, D.
(2001). Bcl-xL Blocks Transforming Growth Factor-beta 1-induced Apoptosis by Inhibiting Cytochrome c Release and Not by Directly Antagonizing Apaf-1-dependent Caspase Activation in Prostate Epithelial Cells. J. Biol. Chem.
276: 26614-26621
[Abstract]
[Full Text]